-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
Quercetin pentaacetate
Category | Respiratory syncytial Virus (RSV) |
CAS | 1064-06-8 |
Description | Quercetin pentaacetate interacts with RSV and inhibits the viral adhesion on cell surface. |
Product Information
Synonyms | Pentaacetylquercetin; Quercetin acetate; 3,3',4',5,7-Pentaacetoxyflavone; NSC 115919; BRN 0380215 |
IUPAC Name | [2-acetyloxy-4-(3,5,7-triacetyloxy-4-oxochromen-2-yl)phenyl] acetate |
Molecular Weight | 512.42 |
Molecular Formula | C25H20O12 |
Canonical SMILES | CC(=O)OC1=C(C=C(C=C1)C2=C(C(=O)C3=C(O2)C=C(C=C3OC(=O)C)OC(=O)C)OC(=O)C)OC(=O)C |
InChI | InChI=1S/C25H20O12/c1-11(26)32-17-9-20(35-14(4)29)22-21(10-17)37-24(25(23(22)31)36-15(5)30)16-6-7-18(33-12(2)27)19(8-16)34-13(3)28/h6-10H,1-5H3 |
InChIKey | JQUHMSXLZZWRHU-UHFFFAOYSA-N |
Boiling Point | 666.4±55.0 °C at 760 mmHg |
Melting Point | 193°C |
Flash Point | 284.7°C |
Purity | ≥98% (HPLC) |
Density | 1.45±0.1 g/cm3 |
Solubility | In vitro: 10 mM in DMSO |
Appearance | Solid powder |
Storage | Store at -20°C |
Complexity | 998 |
Exact Mass | 512.09547607 |
Index Of Refraction | 1.6 |
In Vitro | Quercetin pentaacetate (0-40 μM) shows the obvious inhibition on LPS-induced PGE2 production and COX-2 gene expression and the inhibition in NLA/LPS or L-NAME/LPS co-treated RAW 264.7 cells. |
PSA | 161.71000 |
Target | RSV |
Vapor Pressure | 1.27E-17mmHg at 25°C |
XLogP3-AA | 2.1 |